<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04025385</url>
  </required_header>
  <id_info>
    <org_study_id>KLV-BA-2019-1</org_study_id>
    <nct_id>NCT04025385</nct_id>
  </id_info>
  <brief_title>High-Intensity-Interval-Training in Geriatric Rehabilitation - A Feasibility Study</brief_title>
  <official_title>High-Intensity-Interval-Training in Geriatric Rehabilitation - A Feasibility Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Klinik Valens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Klinik Valens</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study with Patients (40-60 participants) above the age of 65. There will be a comparison of&#xD;
      regular training on ergometer (10 trainings within 2 weeks, 40 min each) to high intensity&#xD;
      interval training on ergometer (6 trainings within 2 weeks, 25 min each). At the beginning&#xD;
      and at the end will be a spiroergometer to measure the individual limits and vO2max, which&#xD;
      will be compared amongst the two groups. To receive a subjective feedback, there will be a&#xD;
      series of questionnaires at the beginning, after one week and at the end. The goal of this&#xD;
      study is to get more information about whether a HII-Training is feasible with elderly&#xD;
      patients and whether they can profit form it.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">July 30, 2019</start_date>
  <completion_date type="Anticipated">December 15, 2021</completion_date>
  <primary_completion_date type="Actual">September 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Will there be a change in outcome of individuals vO2max?</measure>
    <time_frame>2 Weeks</time_frame>
    <description>Measurement of vO2max with spiroergometer at the beginning and end</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Is a High intensity interval training feasible with elderly patients in rehabilitation?</measure>
    <time_frame>1 Day</time_frame>
    <description>Questionnaire (Clinic-intern questionnaire) amongst the involved personal</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Will there be a change in subjective quality of life?</measure>
    <time_frame>2.5 Weeks</time_frame>
    <description>Questionnaires (PROMIS-10, EQ-5D) amongst the participants</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Rehabilitation</condition>
  <condition>Post-Operative Condition</condition>
  <condition>Deconditioning After Acute Hospital</condition>
  <condition>Oncology</condition>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients will participate in regular training units</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HIIT Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will participate in high intensity interval training</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High Intensity Interval Training</intervention_name>
    <description>Training for 25 min with four 1 minute intervals when participants exercise up to 80% of their individual limits.</description>
    <arm_group_label>HIIT Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  cardiopulmonal resilient&#xD;
&#xD;
          -  able to sit on a ergometer&#xD;
&#xD;
          -  knowledge of German written and spoken&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Severe cardiopulmonary restriction (LVEF &lt;30%, conduction abnormalities from AV block&#xD;
             IIb or higher)&#xD;
&#xD;
          -  Absolute cardiopulmonary contraindications (acute coronary syndrome, unstable AP -&gt;&#xD;
             not capable of rehabilitation), uncompensated heart failure (dyspnea at rest,&#xD;
             orthopnea, severe edema)&#xD;
&#xD;
          -  No ischemic events (cardiac, cerebral, peripheral) within the last 3 months&#xD;
&#xD;
          -  Severe pneumatological underlying disease: COPD GOLD 3 and higher or status after&#xD;
             exacerbation within the last 2 weeks, Asthma grade 4&#xD;
&#xD;
          -  Dyalisis reliant&#xD;
&#xD;
          -  Severe psychiatric disorder (severe psychosis, severe depression)&#xD;
&#xD;
          -  Distinct dementia&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Rehazentrum Walenstadtberg</name>
      <address>
        <city>Walenstadtberg</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>June 16, 2019</study_first_submitted>
  <study_first_submitted_qc>July 17, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 18, 2019</study_first_posted>
  <last_update_submitted>March 2, 2021</last_update_submitted>
  <last_update_submitted_qc>March 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Klinik Valens</investigator_affiliation>
    <investigator_full_name>Michael Kruesi</investigator_full_name>
    <investigator_title>Resident Physician, Doctoral Candidate</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

